Robert F. Kennedy Jr. Pledges Overhaul of Vaccine Injury Program Amidst Public Health Concerns
WASHINGTON (AP) — Robert F. Kennedy Jr., serving as Health Secretary, has pledged a comprehensive “fix” for the federal program designed to compensate Americans for vaccine-related injuries. This move has resonated strongly with anti-vaccine advocates, while simultaneously sparking significant apprehension among public health experts.
The Vaccine Injury Compensation Program (VICP): A Brief History
Established by Congress in 1986 under President Ronald Reagan, the Vaccine Injury Compensation Program (VICP) was created as a no-fault system. Its primary aim was to provide swift, efficient compensation for individuals experiencing known, rare vaccine-related injuries, such as severe allergic reactions. The program’s inception was crucial for safeguarding the U.S. vaccine industry, which at the time faced a wave of class-action lawsuits that threatened to drive manufacturers out of business.
Kennedy’s Denouncement and Public Health Fears
Despite its original intent, the VICP has faced growing criticism. Kennedy recently denounced the program as “broken,” alleging “inefficiency, favoritism and outright corruption” on the part of the federal lawyers and adjudicators managing it. While specific reforms remain unspecified by Kennedy, his history as a prominent figure in the anti-vaccine movement has raised concerns that his proposed changes could align with calls to drastically expand the program to include unproven injuries and illnesses not scientifically linked to vaccines.
Concerns Over Broadening Vaccine Injury Definition
Public health experts, such as Jason Schwartz of Yale University, fear that Kennedy’s administration might broaden the definition of a vaccine injury. Anti-vaccine groups have persistently, despite overwhelming scientific consensus to the contrary, suggested a link between vaccines and autism. Schwartz warns that adding autism to the list of compensable injuries “would dramatically increase the number of compensable cases, potentially bankrupting it.” It’s worth noting that in the early 2000s, the program had already ruled against over 5,000 claims from families asserting a vaccine-autism link, citing hundreds of studies discrediting the connection.
Personnel Choices and Financial Ties Fueling Concerns
Further fueling these concerns are Kennedy’s recent personnel choices and his own financial ties. In June, the Department of Health and Human Services awarded a $150,000 contract to an Arizona law firm specializing in vaccine injury cases. Andrew Downing, an attorney from this firm, briefly appeared in the HHS staff directory. Kennedy publicly lauded Downing’s arrival, stating he would be “revolutionizing the Vaccine Injury Compensation Program.” Downing has notably played a leading role in lawsuits against Merck, alleging injuries from its HPV vaccine, Gardasil. Court records indicate approximately 70% of the Gardasil cases he brought against Merck initially started as claims within the federal injury program. However, a judge subsequently dismissed over 120 of these cases, citing “a paucity of evidence” that Gardasil caused the reported problems.
Kennedy himself has been directly involved in Gardasil litigation as both an attorney and consultant. Prior to his government role, he received payments for referring potential Gardasil clients to Wisner Baum, one of the firms suing Merck. Following scrutiny during his confirmation hearings, Kennedy agreed to relinquish his stake in the arrangement and transfer future fees to a non-dependent adult son, who is also an attorney at Wisner Baum.
Consensus on Modernizing an Aging Program
Beyond the controversies, there is a consensus among experts that the nearly 40-year-old program is ripe for modernization. The compensation cap for injury or death remains at $250,000, unchanged since 1986. Similarly, the program continues to operate with only eight adjudicators, known as special masters, tasked with reviewing all cases before the government. This limited staffing contributes to an average case processing time of two to three years. To date, the fund has disbursed $5.4 billion, compensating approximately 40% of all submitted claims.
Experts like Dorit Reiss, a professor at the University of California Hastings College of the Law, emphasize the “ethical obligation” of the U.S. to promptly compensate those harmed by government-recommended vaccines, arguing that “it increases trust in the vaccination program if you have quick, generous compensation.”
Kennedy’s Authority and Potential Reforms
As Health Secretary, Kennedy possesses broad authority to reshape the program. One potential avenue is the addition of new diseases and illnesses to the government’s official table of payable injuries. Dr. Paul Offit, a vaccine researcher at Children’s Hospital of Philadelphia and a long-standing critic of Kennedy, warns that such an expansion, particularly to encompass unproven links like autism, could necessitate increased taxes on vaccines to replenish the compensation fund. This, he argues, would make vaccines more expensive and less accessible, potentially leading to the “disintegrate” of the nation’s vaccine program infrastructure.
Recent events, such as a Senate hearing titled “Voice of the Vaccine Injured,” where representatives from Children’s Health Defense—a non-profit previously chaired by Kennedy that has frequently sued the government over vaccines—testified, underscore the pressure to expand the program. Brian Hooker, the group’s chief science officer, recounted his unsuccessful 16-year effort to secure compensation for his son’s autism, which he attributes to the measles-mumps-rubella vaccine.
Another possible reform could involve removing certain vaccines from the program’s purview, thereby making it easier to pursue civil lawsuits directly against vaccine manufacturers. Currently, individuals claiming vaccine injuries covered by the VICP must first seek compensation through the program before they can resort to civil court. Dr. Offit suggests that juries, often lacking scientific or medical knowledge, might be more swayed in cases where scientific evidence does not support a connection to vaccines. However, even attorneys who regularly bring cases before the VICP, like Leah Durant, acknowledge the process has become more arduous over the years. Durant hopes for changes that make the program “easier for petitioners to navigate,” such as extending the current three-year statute of limitations for claims, which she notes often excludes many potential clients.
